Word

ERVCELLS

Status

Pending

Status Code

641

Status Date

Thursday, January 25, 2024

Serial Number

97910470

Mark Type

4000

Filing Date

Thursday, April 27, 2023

Trademark Owner History

Ervaccine Technologies

Classifications

5 Pharmaceutical preparations for use in the field of oncology; therapeutic vaccines; T-cell therapy preparations for medical use; stem cells for medical use; biological preparations for the prevention and treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of cancer; chemical preparations for medical purposes, namely, for the prevention or treatment of cancer; diagnostic preparations for medical purposes; medicinal preparations for the treatment of infectious diseases and for use in immunotherapy and oncology

44 Medical and surgical services in the field of immunotherapy and oncology; medical diagnosis in the field of oncology; medical testing for diagnostic or treatment purposes; provision of medical information in the field of immunotherapy and oncology; medical analysis for the diagnosis and treatment of persons; genetic testing services for medical purposes

42 Medical laboratory services; biotechnological and pharmaceutical drug research and development services; pharmaceutical and biotechnological research and development; provision of medical and scientific research information in the field of pharmaceuticals; provision of medical and scientific research information in the field of therapeutic vaccines; provision of medical and scientific research information in the field of oncology, immunotherapy, stem cell therapy, and T-cell therapy; Providing medical and scientific research information in the field of clinical trials; screening and selection of molecules for scientific and pharmacological research purposes; research and development in the field of immunotherapy

Trademark Events

Feb 22, 2024

Teas Response To Office Action Received

Jan 25, 2024

Notification Of Non-Final Action E-Mailed

Jan 25, 2024

Non-Final Action E-Mailed

Jan 25, 2024

Non-Final Action Written

Jan 24, 2024

Assigned To Examiner

May 25, 2023

New Application Office Supplied Data Entered

May 1, 2023

New Application Entered